Your browser doesn't support javascript.
loading
The Effect of Vitamin D Supplement Consumption on Premenstrual Syndrome in Vitamin D-Deficient Young Girls: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Abdollahi, Reihaneh; Abiri, Behnaz; Sarbakhsh, Parvin; Kashanian, Maryam; Vafa, Mohammadreza.
Afiliação
  • Abdollahi R; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • Abiri B; Department of Nutrition, Faculty of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, behnaz.abiri@yahoo.com.
  • Sarbakhsh P; Department of Statistics and Epidemiology, School of Public Health, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kashanian M; Department of Obstetrics and Gynecology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Vafa M; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Complement Med Res ; 26(5): 336-342, 2019.
Article em En | MEDLINE | ID: mdl-31104056
ABSTRACT

BACKGROUND:

Premenstrual syndrome (PMS) alludes to a cyclic advent of somatic and psychiatric symptoms that affect some women of reproductive age. Some studies demonstrated that vitamin D was associated with premenstrual symptoms.

OBJECTIVE:

The aim of this study was to evaluate the effect of vitamin D supplementation in the treatment of PMS in vitamin D-deficient young girls.

METHODS:

In this randomized double-blind placebo-controlled trial, 130 vitamin D-deficient girls aged 18-30 years, with PMS, were randomly divided into 2 groups and received a 2,000 IU vitamin D tablet (n = 64) or a placebo (n = 66) every other day for 12 weeks. At the beginning and at the end of week 12, serum 25(OH)-D, premenstrual symptoms, anthropometric indices, dietary intake, physical activity level, and sun exposure were evaluated. Statistical analysis was performed using SPSS version 20. p < 0.05 was considered statistically significant.

RESULTS:

Serum 25(OH)-D levels were significantly elevated in the vitamin D group in comparison to the placebo group after 12 weeks (p < 0.001). There was no significant difference between the 2 groups with regard to 14 symptoms of PMS after 12 weeks of intervention, even after adjustment for the baseline values of anxiety, weeping, and hypersomnia (for all symptoms, p > 0.05). However, in the vitamin D group, scores of nervousness (p < 0.001), job activity reduction (p = 0.01), social activity reduction (p = 0.01), fatigue (p < 0.001), and physical symptoms (p = 0.00) were reduced at the end of the intervention, and these changes were statistically significant compared to baseline. However, these alterations did not reach significance compared with the placebo group (p > 0.05).

CONCLUSION:

It seems that 2,000 IU vitamin D consumption in the vitamin D-deficient young girls with PMS every other day for 12 weeks had no significant impact on other PMS symptoms.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitamina D / Deficiência de Vitamina D / Síndrome Pré-Menstrual / Suplementos Nutricionais Tipo de estudo: Clinical_trials Idioma: En Revista: Complement Med Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitamina D / Deficiência de Vitamina D / Síndrome Pré-Menstrual / Suplementos Nutricionais Tipo de estudo: Clinical_trials Idioma: En Revista: Complement Med Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã